ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model

Molecular Cancer Therapeutics

Volumn 2, Issue 6, 2003, Pages 557-561

  Matsuo, Mitsuhiro ^a   Sakurai, Hiroaki ^a   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; QUINAZOLINE DERIVATIVE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL DIVISION; CELL MOTION; DOSE RESPONSE; DRUG ANTAGONISM; FEMALE; LIVER CELL CARCINOMA; LIVER TUMOR; METASTASIS; MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIVER NEOPLASMS; MICE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0142024593     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Salomon, D. S., Brandt, R., Ciardiello, F., and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19: 183-232, 1995.
2. Nicholson, R. I., Gee, J. M., and Harper, M. E. EGFR and cancer prognosis. Eur. J. Cancer, 37 (Suppl. 4): 9s-15s, 2001.
3. Ito, Y., Takeda, T., Sakon, M., Tsujimoto, M., Higashiyama, S., Noda, K., Miyoshi, E., Monden, M., and Matsuura, N. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br. J. Cancer, 84: 1377-1383, 2001. (Pubitemid 32522107)
4. Woodburn, J. R. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol. Ther., 82: 241-250, 1999. (Pubitemid 29255919)
5. Khazaie, K., Schirrmacher, V., and Lichtner, R. B. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev., 12: 255-274, 1993. (Pubitemid 23293284)
6. Ciardiello, F., and Tortora, G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin. Cancer Res., 7: 2958-2970, 2001. (Pubitemid 32963812)
7. Wakeling, A. E., Nicholson, R. I., and Gee, J. M. Prospects for combining hormonal and nonhormonal growth factor inhibition. Clin. Cancer Res., 7 (12 Suppl.): 4350s-4355s, 2001. (Pubitemid 34031579)
8. Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Pomatico, G., De Placido, S., Bianco, A. R., and Tortora, G. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin. Cancer Res., 6: 2053-2063, 2000. (Pubitemid 30305105)
9. Sirotnak, F. M., Zakowski, M. F., Miller, V. A., Scher, H. I., and Kris, M. G. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin. Cancer Res., 6: 4885-4892, 2000. (Pubitemid 32110433)
10. McCarthy, J. B., Palm, S. L., and Furcht, L. T. Migration by haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin. J. Cell Biol., 97: 772-777, 1983. (Pubitemid 13007195)
11. Murata, J., Ayukawa, K., Ogasawara, M., Fujii, H., and Saiki, I. α-Melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells. Invasion Metastasis, 17: 82-93, 1997. (Pubitemid 28140323)
12. Sawada, S., Murakami, K., Yamaura, T., Sakamoto, T., Ogawa, K., Tsukada, K., and Saiki, I. Intrahepatic metastasis by orthotopic implantation of a fragment of murine hepatoma and its related molecules. Tumour Biol., 22: 154-161, 2001. (Pubitemid 32245411)
13. Gildea, J. J., Harding, M. A., Seraj, M. J., Gulding, K. M., and Theodorescu, D. The role of Ral A in epidermal growth factor receptor-regulated cell motility. Cancer Res., 62: 982-985, 2002. (Pubitemid 34160273)
14. Genersch, E., Schneider, D. W., Sauer, G., Khazaie, K., Schuppan, D., and Lichtner, R. B. Prevention of EGF-modulated adhesion of tumor cells to matrix proteins by specific EGF receptor inhibition. Int. J. Cancer, 75: 205-209, 1998. (Pubitemid 28100060)
15. Lal, A., Glazer, C. A., Martinson, H. M., Friedman, H. S., Archer, G. E., Sampson, J. H., and Riggins, G. J. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res., 62: 3335-3339, 2002. (Pubitemid 34651373)
16. Mendelsohn, J., and Baselga, J. The EGF receptor family as targets for cancer therapy. Oncogene, 19: 6550-6565, 2000. (Pubitemid 32197693)
17. Sawada, S., Murakami, K., Yamaura, T., Mitani, N., Tsukada, K., and Saiki, I. Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma. Jpn. J. Cancer Res., 93: 190-197, 2002. (Pubitemid 34223763)
18. Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Fontanini, G., Cuccato, S., De Placido, S., Bianco, A. R., and Tortora, G. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin. Cancer Res., 7: 1459-1465, 2001. (Pubitemid 32708703)
19. Hirata, A., Ogawa, S., Kometani, T., Kuwano, T., Naito, S., Kuwano, M., and Ono, M. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res., 62: 2554-2560, 2002. (Pubitemid 34462734)
20. Tosetti, F., Ferrari, N., De Flora, S., and Albini, A. 'Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J., 16: 2-14, 2002. (Pubitemid 34027945)